Baudax Bio

NASDAQ BXRX
$0.0100 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 9 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

79.94K
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

1.94M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

-
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

7.99M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-54.55 %

Upcoming events Baudax Bio

All events
No upcoming events scheduled

Stock chart Baudax Bio

Stock analysis Baudax Bio

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.01 21.82
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
- 5.25
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-0.09 9.04
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-0.09 0.65
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
85.25 5.86

Price change Baudax Bio per year

0.51$ 2.90$
Min Max

Summary analysis Baudax Bio

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Baudax Bio

Revenue and net income Baudax Bio

All parameters

Stock news Baudax Bio

All news

Baudax Bio Shares Double After Orphan Drug Designation for TI-168

Baudax Bio Shares Double After Orphan Drug Designation for TI-168

Baudax Bio shares jump on acquisition of TeraImmune

Baudax Bio Shares Surge After Neuromuscular Drug Trial Results

Baudax Bio Shares Surge After Neuromuscular Drug Trial Results

Baudax Bio Shares Drop 17% After Tuesday Rise on BX-1000 Trial Results

Baudax Bio Shares Drop 17% After Tuesday Rise on BX-1000 Trial Results

Baudax Bio Shares Rise 81% After Successful Trial Results for BX1000

Baudax Bio Shares Rise 81% After Successful Trial Results for BX1000

Baudax Bio Shares Up 30%

Baudax Bio Shares Up 30%

Baudax Bio Shares Tumble Premarket After Public Offering >BXRX

Baudax Bio Shares Tumble Premarket After Public Offering >BXRX

Baudax Bio Shares Tumble Premarket on Public Offering >BXRX

Baudax Bio Shares Tumble Premarket on Public Offering >BXRX

Baudax Bio Shares Drop 28%, Announces Proposed Public Offering

Baudax Bio Shares Drop 28%, Announces Proposed Public Offering

Лидеры и аутсайдеры Уолл-cтрит: California Resources, Baudax Bio, Trans World Entertainment

About company Baudax Bio

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMBA) that is in phase I clinical trial; BX2000, an ultrashort-acting NMBA, which is in pre-clinical trial; and BX3000, an NMBA reversal agent, which is under pre-clinical trial, as well as Dex-IN, a proprietary intranasal formulation of dexmedetomidine, which is under phase II clinical trial. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.
Address:
490 Lapp Road, Malvern, PA, United States, 19355
Company name: Baudax Bio
Issuer ticker: BXRX
ISIN: US07160F1075
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2019-11-22
Sector: Healthcare
Industry: Biotechnology
Site: https://www.baudaxbio.com

On which stock exchange are Baudax Bio (BXRX) stocks traded?

Baudax Bio (BXRX) stocks are traded on NASDAQ.

What is the ticker of Baudax Bio stocks (BXRX)?

The stock ticker of Baudax Bio’s stocks or in other words, the code is BXRX. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Baudax Bio (BXRX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Baudax Bio (BXRX) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Baudax Bio (BXRX) stocks traded?

Baudax Bio (BXRX) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Baudax Bio (BXRX) stocks today?

The current price of Baudax Bio stocks on 12.05.2024 is 0.01 dollars. per share.

What is the dynamics of Baudax Bio (BXRX) stocks from the beginning of the year?

Baudax Bio (BXRX) quotes have increased by -57.81% from the beginning of the year up to 0.01 dollars. per 1 stocks.

How much did Baudax Bio (BXRX) stocks increase in мае 2024?

This month Baudax Bio (BXRX) quotes have increased by 0% to 0.01 dollars. per share.

How much are Baudax Bio (BXRX) stocks worth?

Today, on October, 12.05.2024 Baudax Bio’s (BXRX) stocks cost 0.01 dollars..

What is the market capitalization of Baudax Bio (BXRX)?

Capitalization is the market value of Baudax Bio (BXRX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 12.05.2024, the market capitalization of Baudax Bio (BXRX) is estimated at about 79935 dollars.